Lista de obras - Matthew Masoli - Dominio Público Uruguay

"Difficult asthma": not as easy as you think

artículo científico publicado en 2015

A qualitative study of the impact of severe asthma and its treatment showing that treatment burden is neglected in existing asthma assessment scales

artículo científico publicado en 2014

An adult asthma assessment and management protocol for use in the emergency department.

artículo científico publicado en 2003

Anti-interleukin-5 therapy in patients with severe asthma: from clinical trials to clinical practice

artículo científico publicado en 2020

Asthma exacerbations and inhaled corticosteroids

artículo científico publicado en 2004

Budesonide once versus twice-daily administration: meta-analysis.

artículo científico publicado en 2004

Building Bridges for Innovation in Ageing: Synergies between Action Groups of the EIP on AHA.

artículo científico publicado en 2017

Clinical dose-response relationship of fluticasone propionate in adults with asthma

artículo científico publicado en 2004

Comparison of the effects of pulmonary and extra-pulmonary symptoms on health-related quality of life in patients with severe asthma

artículo científico publicado en 2020

Defining a Severe Asthma Super-Responder: Findings from a Delphi Process

Dose-response relationship for risk of non-vertebral fracture with inhaled corticosteroids.

artículo científico publicado en 2008

Dose-response relationship of inhaled budesonide in adult asthma: a meta-analysis

artículo científico publicado en 2004

Erratum to: Building bridges for innovation in ageing: Synergies between action groups of the EIP on AHA

article

Evaluation of Real-World Mepolizumab Use in Severe Asthma across Europe - the SHARP experience with privacy-preserving federated analysis

artículo científico publicado en 2023

Evidence for similarity in symptoms and mechanism: The extra-pulmonary symptoms of severe asthma and the polysymptomatic presentation of fibromyalgia

scientific article published on 23 August 2019

Fixed and adjustable dose asthma action plans based on combination therapy: a pilot study.

artículo científico publicado en 2005

Fluticasone given once versus twice a day: meta-analysis.

artículo científico publicado en 2005

How patient participation was used to develop a questionnaire that is fit for purpose for assessing quality of life in severe asthma

artículo científico publicado en 2018

Impact of omalizumab on treatment of severe allergic asthma in UK clinical practice: a UK multicentre observational study (the APEX II study).

artículo científico publicado en 2016

Improving quality of life relies on valid outcome measures as well as drugs

artículo científico publicado en 2017

Increasing compliance with inhaled corticosteroids through the use of combination therapy

artículo científico publicado en 2004

Inhaled fluticasone propionate and adrenal effects in adult asthma: systematic review and meta-analysis.

artículo científico publicado en 2006

Long-term Safety and Clinical Benefit of Mepolizumab in Patients With the Most Severe Eosinophilic Asthma: The COSMEX Study

artículo científico publicado en 2019

Metered dose inhalers: a need for dose counters

artículo científico publicado en 2005

Moderate dose inhaled corticosteroids plus salmeterol versus higher doses of inhaled corticosteroids in symptomatic asthma.

artículo científico publicado en 2005

Optimal starting dose of inhaled corticosteroids in adult asthma: why has it taken so long?

artículo científico publicado en 2005

Systematic review of the dose-response relation of inhaled fluticasone propionate.

artículo científico publicado en 2004

The 24 h duration of bronchodilator action of the budesonide/formoterol combination inhaler

artículo científico publicado en 2005

The 24 h duration of bronchodilator action of the salmeterol/fluticasone combination inhaler

artículo científico publicado en 2004

The construction and validation of the Severe Asthma Questionnaire

artículo científico publicado en 2018

The dose-response relationship of inhaled corticosteroids in asthma

artículo científico publicado en 2004

The global burden of asthma: executive summary of the GINA Dissemination Committee report

artículo científico publicado en 2004

The use of the self-management plan system of care in adult asthma

artículo científico publicado en 2004

Use of isotonic nebulised magnesium sulphate as an adjuvant to salbutamol in treatment of severe asthma in adults: randomised placebo-controlled trial.

artículo científico publicado en 2003

Validation of subscales of the Severe Asthma Questionnaire (SAQ) using exploratory factor analysis (EFA)

artículo científico publicado en 2020

What to do at step 3 of the asthma guidelines—increase the dose of inhaled corticosteroids or add a long-acting β-agonist drug?

artículo científico publicado en 2003

Lista de obras de Matthew Masoli

"Difficult asthma": not as easy as you think

A qualitative study of the impact of severe asthma and its treatment showing that treatment burden is neglected in existing asthma assessment scales

An adult asthma assessment and management protocol for use in the emergency department.

Anti-interleukin-5 therapy in patients with severe asthma: from clinical trials to clinical practice

Asthma exacerbations and inhaled corticosteroids

Budesonide once versus twice-daily administration: meta-analysis.

Building Bridges for Innovation in Ageing: Synergies between Action Groups of the EIP on AHA.

Clinical dose-response relationship of fluticasone propionate in adults with asthma

Comparison of the effects of pulmonary and extra-pulmonary symptoms on health-related quality of life in patients with severe asthma

Defining a Severe Asthma Super-Responder: Findings from a Delphi Process

Dose-response relationship for risk of non-vertebral fracture with inhaled corticosteroids.

Dose-response relationship of inhaled budesonide in adult asthma: a meta-analysis

Erratum to: Building bridges for innovation in ageing: Synergies between action groups of the EIP on AHA

Evaluation of Real-World Mepolizumab Use in Severe Asthma across Europe - the SHARP experience with privacy-preserving federated analysis

Evidence for similarity in symptoms and mechanism: The extra-pulmonary symptoms of severe asthma and the polysymptomatic presentation of fibromyalgia

Fixed and adjustable dose asthma action plans based on combination therapy: a pilot study.

Fluticasone given once versus twice a day: meta-analysis.

How patient participation was used to develop a questionnaire that is fit for purpose for assessing quality of life in severe asthma

Impact of omalizumab on treatment of severe allergic asthma in UK clinical practice: a UK multicentre observational study (the APEX II study).

Improving quality of life relies on valid outcome measures as well as drugs

Increasing compliance with inhaled corticosteroids through the use of combination therapy

Inhaled fluticasone propionate and adrenal effects in adult asthma: systematic review and meta-analysis.

Long-term Safety and Clinical Benefit of Mepolizumab in Patients With the Most Severe Eosinophilic Asthma: The COSMEX Study

Metered dose inhalers: a need for dose counters

Moderate dose inhaled corticosteroids plus salmeterol versus higher doses of inhaled corticosteroids in symptomatic asthma.

Optimal starting dose of inhaled corticosteroids in adult asthma: why has it taken so long?

Systematic review of the dose-response relation of inhaled fluticasone propionate.

The 24 h duration of bronchodilator action of the budesonide/formoterol combination inhaler

The 24 h duration of bronchodilator action of the salmeterol/fluticasone combination inhaler

The construction and validation of the Severe Asthma Questionnaire

The dose-response relationship of inhaled corticosteroids in asthma

The global burden of asthma: executive summary of the GINA Dissemination Committee report

The use of the self-management plan system of care in adult asthma

Use of isotonic nebulised magnesium sulphate as an adjuvant to salbutamol in treatment of severe asthma in adults: randomised placebo-controlled trial.

Validation of subscales of the Severe Asthma Questionnaire (SAQ) using exploratory factor analysis (EFA)

What to do at step 3 of the asthma guidelines—increase the dose of inhaled corticosteroids or add a long-acting β-agonist drug?